Surface Oncology Inc
SURF
Get informed when a big investor buys or sells
+ FollowMarket Cap$65.08M
Close$
$2.31
115.8% upside
Current Fair Value
115.8% upsideUndervalued by 115.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $65.08 Million |
|---|---|
| Enterprise Value | $59.73 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.17 |
| Beta | 1.75 |
| Outstanding Shares | 60,717,899 |
Return
| Return on Equity | -191.16% |
|---|---|
| Return on Assets | -142.42% |
| Return on Invested Capital | -174.72% |
Valuation & Multiples
| P/E Ratio | -0.91 |
|---|---|
| PEG | -9.86 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1.99 |
| Enterprise Value to EBIT | -0.7 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.16 |
| Debt to Equity | 0.19 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Surface Oncology Inc
CEO: J. Jeffrey Goater